Lawsuits from Accutane against Roche

Accutane manufactured by the pharmacy company Roche for the treatment of severe acne has been proven to leave a number of side effects and be the cause of (IBD)  Inflammatory Bowel Disease, Crohn’s Disease,and Ulcerative Colitis.

These diseases can be very harmful and inconvenient for those individuals suffering.

A pre-trial settlement with Roche Laboratories, the drug manufacturer of the prescription drug Accutane, was reached with a man who claimed that he developed severe bowel problems after using the drug Accutane to treat acne.

The drug manufacturer Roche has asked Madison County Circuit Judge David Hylla to approve the Accutane settlement, according to a report in The Madison Record. The case, which was brought by plaintiff Jason Peipert, also involves a medical malpractice claim against an Illinois doctor, who may also be in settlement talks with the plaintiff.

Peipert alleges that Dr. Daniel Goran prescribed him Accutane to treat his acne, and that the drug caused him to develop the debilitating condition, inflammatory bowel disease (IBD). The case was set to go to trial on April 19, but start of the trial was delayed due the potential settlement with Accutane manufacturers.

The drug manufacturer Roche has nearly 1,000 Accutane lawsuits ahead of them, which involve allegations that the drug maker failed to adequately warn users about the potential side effects of Accutane. Currently the company has lost all six Accutane bowel disease trials that have reached a jury thus far, with verdict totaling $56 million.

The largest judgment so far was awarded to Andrew McCarrell, of Alambama, who received $25.16 million in compensation by a New Jersey jury in an Accutane trial earlier this year.

Details of this particular Accutane lawsuit settlement with Peipert have not been disclosed. However, it should go without saying that the terms of the agreement do not include an admission of guilt from the pharmaceutical giant Roche, and Peipert has reportedly agreed not to bring another case against Roche in the future.